pharma · Ovarian Cancer · Breast Cancer · ZNTL
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals (United is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker ZNTL. Primary therapeutic focus areas include Ovarian Cancer, Breast Cancer, High-Grade Serous Ova
10275 Science Center Dr, Suite 200, San Diego, California 92121, US HQ
123 Employees
Public company Type
ZNTL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10275 Science Center Dr, Suite 200, San Diego, California 92121, US
- Employees
- 123
- Programs
- 14
- Drugs
- 4
- Patents
- 0
Azenosertib
Phase 2 · small molecule · Ovarian Cancer
Azenosertib for Ovarian Cancer is a Phase 2 program (small_molecule) at Zentalis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code ZN-c3-006
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zentalis Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Ovarian Cancer
- Status
- completed
- Trials
- 1